23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.02%
Revenue growth exceeding 1.5x Insurance - Life median of 1.29%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.
3.02%
Gross profit growth exceeding 1.5x Insurance - Life median of 1.29%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.
6.13%
EBIT growth of 6.13% while Insurance - Life median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
6.13%
Operating income growth of 6.13% while Insurance - Life median is zero. Walter Schloss might see a modest advantage that can expand.
2.79%
Net income growth near Insurance - Life median of 3.08%. Charlie Munger would see common industry factors at play.
2.82%
EPS growth exceeding 1.5x Insurance - Life median of 1.75%. Joel Greenblatt would confirm if consistent earnings expansion underpins these gains.
2.81%
Diluted EPS growth 75-90% of Insurance - Life median of 3.33%. John Neff would press for more efficient cost or share repurchases.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.99%
OCF growth of 0.99% while Insurance - Life is zero. Walter Schloss might see a modest positive difference, which can compound over time.
0.99%
FCF growth of 0.99% while Insurance - Life median is zero. Walter Schloss might see a slight edge that could compound over time.
141.75%
10Y revenue/share CAGR exceeding 1.5x Insurance - Life median of 40.61%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.
95.69%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 51.92%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
106.69%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 29.95%. Joel Greenblatt might see a short-term competitive advantage at play.
No Data
No Data available this quarter, please select a different quarter.
369.11%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 75.89%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
198.96%
3Y OCF/share growth > 1.5x Insurance - Life median of 18.11%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
333.55%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 151.61% over a decade. Joel Greenblatt might see a standout compounder of earnings.
289.77%
5Y net income/share CAGR > 1.5x Insurance - Life median of 149.33%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
146.89%
3Y net income/share CAGR > 1.5x Insurance - Life median of 67.65%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
234.04%
Equity/share CAGR of 234.04% while Insurance - Life median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
170.65%
5Y equity/share CAGR > 1.5x Insurance - Life median of 52.96%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
140.83%
3Y equity/share CAGR > 1.5x Insurance - Life median of 21.67%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.40%
Below 50% of Insurance - Life median. Jim Chanos suspects stagnation or limited capital availability for expansions.
1.26%
Below 50% of Insurance - Life median. Jim Chanos suspects deeper issues blocking net worth accumulation.
-0.34%
Debt is shrinking while Insurance - Life median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
-2.77%
SG&A decline while Insurance - Life grows. Seth Klarman sees potential cost advantage or a risk if it hurts future growth.